Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CR6086 |
Trade Name | |
Synonyms | CR 6086|CR-6086 |
Drug Descriptions |
CR6086 is an antagonist of the prostaglandin E2 receptor 4 (EP4) with potential immunomodulatory activity, and may enhance inhibition of tumor growth (PMID: 29490676;Cancer Res 2020;80(16 Suppl):Abstract nr 2208). |
DrugClasses | |
CAS Registry Number | 1417742-86-9 |
NCIT ID | C186659 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Balstilimab + CR6086 | Balstilimab CR6086 | 0 | 1 |
CR6086 | CR6086 | 0 | 0 |